Literature DB >> 7768983

Cortisol downregulates osteoblast alpha 1 (I) procollagen mRNA by transcriptional and posttranscriptional mechanisms.

A M Delany1, B Y Gabbitas, E Canalis.   

Abstract

Glucocorticoids decrease osteoblast proliferation and type I collagen production, and this may play a role in the development of glucocorticoid-induced osteoporosis. Osteoblast-enriched cultures derived from fetal rat calvaria were used to determine the mechanisms by which cortisol decreases alpha 1 (I) procollagen expression in bone cells. A 24 h treatment with cortisol decreased collagen synthesis in these cultures in a dose-dependent manner. Cortisol decreased alpha 1 (I) procollagen transcripts in a dose- and time-dependent manner as well. Repression of alpha 1 (I) procollagen transcripts was evident as early as 2 h of treatment and was maximal after 48 h of treatment. Nuclear run-off assays showed that cortisol downregulated transcription of the alpha 1 (I) procollagen gene. In addition, pretreatment with cortisol decreased the stability of alpha 1 (I) procollagen mRNA in transcription-arrested osteoblast cultures. The ability of cortisol to downregulate alpha 1 (I) procollagen transcripts was sensitive to cycloheximide treatment, suggesting that the gene is under "secondary control" by glucocorticoids. Since cortisol decreases alpha 1 (I) procollagen gene transcription in osteoblasts but does not affect alpha 1 (I) procollagen gene transcription in fibroblasts, we suggest that the mechanisms controlling glucocorticoid repression of collagen expression are cell-type specific.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7768983     DOI: 10.1002/jcb.240570314

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  25 in total

Review 1.  Hormonal regulation of physiological cell turnover and apoptosis.

Authors:  R D Medh; E B Thompson
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

Review 2.  Genetic approaches to determine the role of glucocorticoid signaling in osteoblasts.

Authors:  John R Harrison; Henning W Woitge; Barbara E Kream
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

Review 3.  Glucocorticoid-Induced Osteoporosis.

Authors:  Baruch Frenkel; Wendy White; Jan Tuckermann
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

4.  [Insufficiency fractures in rheumatology. Case report and overview].

Authors:  R Dreher; F Buttgereit; W Demary; B Görtz; G Hein; P Kern; A Schulz
Journal:  Z Rheumatol       Date:  2006-09       Impact factor: 1.372

Review 5.  Mechanisms of glucocorticoid action in bone.

Authors:  Ernesto Canalis
Journal:  Curr Osteoporos Rep       Date:  2005-09       Impact factor: 5.096

6.  Ultrastructural characteristics of glucocorticoid-induced osteoporosis.

Authors:  B Bouvard; M Audran; E Legrand; D Chappard
Journal:  Osteoporos Int       Date:  2009-06       Impact factor: 4.507

7.  Plumbagin protects against glucocorticoid-induced osteoporosis through Nrf-2 pathway.

Authors:  Shuai Zhang; Dong Li; Jing-Yan Yang; Ting-Bin Yan
Journal:  Cell Stress Chaperones       Date:  2015-05-05       Impact factor: 3.667

Review 8.  Bone involvement in exogenous hypercortisolism.

Authors:  L Sinigaglia; D Mazzocchi; M Varenna
Journal:  J Endocrinol Invest       Date:  2008-04       Impact factor: 4.256

Review 9.  Pediatric Osteoporosis: Diagnosis and Treatment Considerations.

Authors:  Edoardo Marrani; Teresa Giani; Gabriele Simonini; Rolando Cimaz
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

10.  Towards understanding the dose and timing effect of hydrocortisone treatment on the scleral ossicle system within the chicken eye.

Authors:  Christine L Hammer; Tamara A Franz-Odendaal
Journal:  J Anat       Date:  2017-12-06       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.